Agilent Joins the National Institute for Innovation in Manufacturing to Advance Biomanufacturing
19 Abril 2022 - 9:00AM
Business Wire
Support for biologics manufacturability and Industry 4.0
initiatives
Agilent Technologies Inc. (NYSE: A) announced that it has joined
the National Institute for Innovation in Manufacturing to Advance
Biomanufacturing (NIIMBL). Membership in NIIMBL demonstrates
Agilent’s commitment to supporting biopharma and biotherapeutics
customer challenges through partnership and innovation using tools
and workflows.
The biomanufacturing industry is increasingly interested in
continuous manufacturing solutions that can reduce the
manufacturing footprint and improve supply chain logistics and
biotherapeutic access by enabling manufacturing to move closer to
patients, especially in underserved areas. The NIIMBL mission is to
accelerate biopharmaceutical innovation, support the development of
standards that enable more efficient and rapid manufacturing
capabilities, and educate and train a world-leading
biopharmaceutical manufacturing workforce, which will fundamentally
advance U.S. competitiveness in the industry.
“Agilent has long played a key role in providing trusted answers
for the analytical needs of the biopharmaceutical industry,” said
Agilent CEO Mike McMullen. “The prominence of biopharmaceuticals
coupled with the advent of precision cell and gene biotherapeutics
has further spurred the need for innovative measurement tools to
help deliver life-saving drugs and diagnostics to patients.”
Agilent’s online HPLC sampling portfolio, cellular imaging, and
real-time sensor technologies exemplify how the company can help
address current and emerging needs. Additionally, Agilent’s NIIMBL
membership will allow us to work closely with all continuum
partners to help shape the future of innovation and standards used
in bioprocess development and biomanufacturing.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in the
life sciences, diagnostics, and applied chemical markets,
delivering insight and innovation that advance the quality of life.
Agilent’s full range of solutions includes instruments, software,
services, and expertise that provide trusted answers to our
customers' most challenging questions. The company generated
revenue of $6.32 billion in fiscal 2021 and employs 17,000 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, please
subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn,
Twitter, and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220419005201/en/
Naomi Goumillout Agilent Technologies +1.781.266.2819
naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024